Shen Yong-Mei, Yang Xiao-Chun, Zhang Mei-Hua, Shen Jun-Kang, Sun Yi-Hui
Department of Radioimmunoassay Center, The Second Affiliated Hospital, Soochow University, Suzhou, Jiangsu, 215004, People's Republic of China.
Ai Zheng. 2008 May;27(5):496-504.
BACKGROUND & OBJECTIVE: Point mutation of K-ras gene and overexpression of insulin-like growth factor receptor type 1 (IGF-IR) may contribute to the progression and aggressiveness of pancreatic cancer. Antisense oligodeoxynucleotide (ASODN) against K-ras mRNA and IGF-IR mRNA may inhibit the proliferation of pancreatic cancer cells. This study was to investigate the combinational effects of K-ras ASODN and IGF-IR ASODN on proliferation and apoptosis of human pancreatic cancer Patu8988 cells in vitro and in vivo.
K-ras gene point mutation in Patu8988 cells was detected by polymerase chain reaction using special sequence primers (PCR-SSP) and sequence analysis. According to the mutation style, K-ras ASODN was designed and composed. K-ras ASODN and IGF-IR ASODN were transfected into Patu8988 cells alone or in combination. Cell proliferation was analyzed by MTT and colony forming assay. The morphologic changes of Patu8988 cells were assessed under transmission electron microscope. The expression of K-ras and IGF-IR mRNA and protein in Patu8988 cells was measured by reverse transcription-polymerase chain reaction (RT-PCR) and flow cytometry (FCM). Cell apoptosis was determined by FCM. The combinational antitumor activity of K-ras ASODN and IGF-IR ASODN was evaluated in BALB/c nude mice bearing human pancreatic cancer inoculated with Patu8988 cells.
The point mutation of K-ras gene at codon 12 was detected in Patu8988 cells, and the mutation style was GGT-->GTT. Either 2-32 microg/mL K-ras ASODN or IGF-IR ASODN inhibited proliferation and induced apoptosis of Patu8988 cells. This effect was more obvious when K-ras ASODN and IGF-IR ASODN were used in combination than used alone (P<0.01). In tumor-bearing mice, the inhibitory effect on the growth of transplanted pancreatic cancer was more obvious when K-ras ASODN and IGF-IR ASODN were used in combination than used alone (P<0.01).
K-ras ASODN combined with IGF-IR ASODN could cooperatively inhibit the proliferation of Patu8988 cells and induce their apoptosis via down-regulating K-ras and IGF-IR expression.
K-ras基因点突变及胰岛素样生长因子1型受体(IGF-IR)过表达可能与胰腺癌的进展及侵袭性有关。针对K-ras mRNA和IGF-IR mRNA的反义寡脱氧核苷酸(ASODN)可能抑制胰腺癌细胞的增殖。本研究旨在探讨K-ras ASODN与IGF-IR ASODN联合应用对人胰腺癌Patu8988细胞体外及体内增殖和凋亡的影响。
采用特殊序列引物聚合酶链反应(PCR-SSP)及序列分析检测Patu8988细胞中K-ras基因点突变。根据突变类型设计并合成K-ras ASODN。将K-ras ASODN和IGF-IR ASODN单独或联合转染至Patu8988细胞。采用MTT法和集落形成试验分析细胞增殖情况。在透射电子显微镜下观察Patu8988细胞的形态变化。采用逆转录-聚合酶链反应(RT-PCR)和流式细胞术(FCM)检测Patu8988细胞中K-ras和IGF-IR mRNA及蛋白的表达。通过FCM检测细胞凋亡情况。在接种Patu8988细胞的荷人胰腺癌BALB/c裸鼠中评估K-ras ASODN与IGF-IR ASODN联合的抗肿瘤活性。
在Patu8988细胞中检测到K-ras基因第12密码子的点突变,突变类型为GGT→GTT。2-32μg/mL的K-ras ASODN或IGF-IR ASODN均可抑制Patu8988细胞的增殖并诱导其凋亡。K-ras ASODN与IGF-IR ASODN联合应用时,该作用比单独应用更明显(P<0.01)。在荷瘤小鼠中,K-ras ASODN与IGF-IR ASODN联合应用对移植性胰腺癌生长的抑制作用比单独应用更明显(P<0.01)。
K-ras ASODN与IGF-IR ASODN联合应用可协同抑制Patu8988细胞的增殖,并通过下调K-ras和IGF-IR的表达诱导其凋亡。